Focus: enGenes Biotech is a Vienna-based biotech company specializing in customized solutions for recombinant protein production, serving the broader life sciences and pharmaceutical manufacturing ecosystem. The company operates as a public entity founded in 2014 with a technology-enabled, solutions-driven business model.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow enGenes Biotech to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet.
Help build intelligence for enGenes Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from enGenes Biotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo